Stocks: Merck hits blue chips, but tech shares rally
187292
NEW YORK Merck led blue-chip stocks lower Thursday as the No. 2 US drug maker reduced its profit forecast after withdrawing its Vioxx painkiller.
495965
Tokyo stocks rallied 1.5 percent Monday as technology blue chips got a boost from a US brokerage&#39;s buy recommendation and the US Nasdaq&#39;s strength Friday.
446577
US blue chips rose on Thursday, led by tobacco stocks, while technology share were under pressure by a warning from Applied Materials Inc.
769773
TRENTON, N.J. -- Shares of drug maker Merck &amp; Co. dropped 2.5 percent in heavy trading yesterday, a day after medical journal reports offered fresh ammunition to patients suing over its withdrawn painkiller Vioxx.
240200
U.S. tech stocks rose on Wednesday, boosted by Cisco Systems Inc.'s  strong profits and outlook which reinforced optimism about earnings, while blue chip stocks pared gains as the price of oil fell.
203287
U.S. stocks rallied on Tuesday, with the Dow closing at its highest level in 3 1/2 years, boosted by a rebound in beaten-down drugmaker Pfizer Inc. , while tech stocks got a lift from a broker upgrade of Intel Corp. .
656659
Technology stocks climbed near a  2-month high on Monday, as investors seeing value in a battered  group bought software and semiconductor shares, while higher  crude oil prices limited blue-chip gains.
604801
U.S. stocks rose Monday on strong Merck & Co. profits and news of a nearly $18 billion oil services takeover, while Treasury bonds eased as reduced fears about the subprime credit market made riskier assets attractive again.
143390
Blue-chip and tech stocks ended  slightly higher on Monday as investors paused after last week's  election rally and braced for U.S. interest-rate hikes that  threaten to raise companies' costs.
140293
NEW YORK Concerned about third-quarter earnings offset a surprise drop in wholesale prices, keeping stocks mixed Friday. Blue chips dropped on profit warnings from Alcoa, a Dow component, and Visteon, while technology shares rose on takeover expectations.
552579
Company earned 60 cents a share, down from 83 cents a year earlier; Vioxx linked to heart attacks. NEW YORK  - Merck &amp; Co.
474839
The Toronto stock market posted a small gain today, pushed higher by the gold sector, but drug company Merck &amp; Co. took the Dow Jones industrial average into the red after taking its arthritis drug Vioxx off the market.
199560
The tech-driven Nasdaq Composite Index got a 1 percent boost on Thursday on gains in the semiconductor sector, but the blue-chip Dow ended down slightly after Caterpillar Inc.
17811
Nastech shares jump before the bell after companies say they will jointly create the new treatment. NEW YORK  - Merck &amp; Co.
531813
U.S. stocks ended higher on Wednesday,  with the dollar strengthening and shares of drugmaker Merck &  Co. MRK.N helping to lift the blue-chip Dow after the company  issued a forecast that was not as weak as some investors had  expected.
392641
Drugmaker Merck & Co. Inc.  boosted its 2007 earnings forecast on Wednesday, based on early revenue indications from a range of products, sending its shares up nearly 3 percent in early electronic trading.
557154
U.S. stocks held solid gains on  Wednesday, as oil prices held below $42 a barrel and healthcare  stocks rose, with shares of drugmaker Merck & Co. MRK.N up  after issuing a 2005 forecast that was better than some  analysts had expected.